We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
-14.02%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$8.88B
AUM Growth
-$1.57B
Cap. Flow
+$103M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.32%
Holding
763
New
20
Increased
297
Reduced
294
Closed
39

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$28M
2
PRGO icon
Perrigo
PRGO
+$25.4M
3
J icon
Jacobs Solutions
J
+$23.4M
4
ICUI icon
ICU Medical
ICUI
+$21.3M
5
SSB icon
SouthState Bank Corp
SSB
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.06%
3 Industrials 15.07%
4 Financials 12.92%
5 Consumer Discretionary 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.95T
$186M 2.1%
724,765
+11,762
+2% +$3.19M
AAPL icon
2
Apple
AAPL
$4.81T
$182M 2.05%
1,333,477
+101,917
+8% +$15.4M
AMZN icon
3
Amazon
AMZN
$2.66T
$154M 1.73%
1,450,868
-241,852
-14% -$30.3M
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.22T
$146M 1.64%
1,333,680
-23,240
-2% -$2.75M
EQC
5
DELISTED
Equity Commonwealth
EQC
$121M 1.37%
4,408,703
+151,276
+4% +$4.09M
UNH icon
6
UnitedHealth
UNH
$396B
$121M 1.36%
236,020
-17,672
-7% -$8.87M
ADBE icon
7
Adobe
ADBE
$90.3B
$114M 1.29%
312,679
-9,285
-3% -$3.78M
PWR icon
8
Quanta Services
PWR
$95.9B
$114M 1.28%
907,214
-26,514
-3% -$3.25M
MTD icon
9
Mettler-Toledo International
MTD
$25.7B
$113M 1.27%
98,318
+11,070
+13% +$13.9M
ROP icon
10
Roper Technologies
ROP
$36.6B
$109M 1.23%
276,794
-13,472
-5% -$5.86M
V icon
11
Visa
V
$677B
$108M 1.22%
549,775
-4,731
-0.9% -$978K
TMO icon
12
Thermo Fisher Scientific
TMO
$195B
$106M 1.2%
195,468
+20,051
+11% +$11M
ZTS icon
13
Zoetis
ZTS
$31.6B
$106M 1.19%
615,885
-9,344
-1% -$1.62M
MRVL icon
14
Marvell Technology
MRVL
$187B
$98.3M 1.11%
2,257,677
-142,012
-6% -$8.05M
COTY icon
15
Coty
COTY
$2.42B
$94.8M 1.07%
11,830,027
-117,463
-1% -$882K
DHR icon
16
Danaher
DHR
$127B
$83.1M 0.94%
369,884
-9,483
-2% -$2.18M
MCK icon
17
McKesson
MCK
$97.3B
$82.8M 0.93%
253,894
-43,856
-15% -$14M
CTLT
18
DELISTED
CATALENT, INC.
CTLT
$80.6M 0.91%
751,460
+53,420
+8% +$5.44M
PRGS icon
19
Progress Software
PRGS
$1.62B
$78.8M 0.89%
1,739,956
+20,875
+1% +$993K
JPM icon
20
JPMorgan Chase
JPM
$918B
$77.7M 0.87%
689,492
+17,912
+3% +$2.22M
ARES icon
21
Ares Management
ARES
$27.3B
$76.2M 0.86%
1,339,514
-17,568
-1% -$1.22M
TECH icon
22
Bio-Techne
TECH
$11.2B
$75.3M 0.85%
868,964
-33,120
-4% -$3.1M
HAIN icon
23
Hain Celestial
HAIN
$53.2M
$75.1M 0.85%
3,163,435
-997,161
-24% -$28.4M
ZBRA icon
24
Zebra Technologies
ZBRA
$12.6B
$73.1M 0.82%
248,623
+3,390
+1% +$1.18M
RRX icon
25
Regal Rexnord
RRX
$13.7B
$71.8M 0.81%
632,788
-12,249
-2% -$1.56M

Similar funds

Segall Bryant & Hamill's Q2 2022 Portfolio in Review

As of Q2 2022, Segall Bryant & Hamill held 763 positions worth $8.88B, down 15% from $10.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Segall Bryant & Hamill's Q2 2022 filing shows 20 new, 297 increased, 294 reduced and 39 closed positions. Its largest new stake was Perrigo: 684,450 shares worth $27.7M. The largest sale was Western Alliance Bancorporation, an estimated $35M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Segall Bryant & Hamill's largest Q2 2022 buy was Perrigo: 684,450 shares worth $27.7M.
  • Segall Bryant & Hamill added most to Unilever in Q2 2022, an estimated $28M increase.
  • Segall Bryant & Hamill's biggest Q2 2022 reduction was Western Alliance Bancorporation, cutting an estimated $35M.
  • Segall Bryant & Hamill fully exited Anaplan, Inc. in Q2 2022, selling an estimated $22.7M.
  • Segall Bryant & Hamill's ten largest holdings make up 15% of its $8.88B portfolio in Q2 2022.
  • Segall Bryant & Hamill opened 20 new positions and closed 39 in Q2 2022.
  • Segall Bryant & Hamill's portfolio value fell 15% quarter-over-quarter to $8.88B.

Based on Segall Bryant & Hamill's 13F filing for Q2 2022, filed 15 Aug 2022.